Analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
Shares of CPHI opened at $0.24 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. China Pharma has a one year low of $0.17 and a one year high of $1.21. The business’s 50 day simple moving average is $0.21 and its 200-day simple moving average is $0.27.
China Pharma (NYSE:CPHI – Get Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%. The firm had revenue of $0.93 million for the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- About the Markup Calculator
- CarMax’s Impressive Rally: What Investors Should Watch Next
- The Significance of Brokerage Rankings in Stock Selection
- MarketBeat Week in Review – 9/23 – 9/27
- Why Are Stock Sectors Important to Successful Investing?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
